. 2021 Apr 12;87(11):4183–4196. doi: 10.1111/bcp.14838
© 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
FIGURE 1.
ODs for the treatment of haemophilia A and B (n = 41)